Staphylococcus colonization of the skin and antimicrobial peptides

References

• Kloos W, Schleifer KH. Staphylococcus. In: Bergey’s Manual of Systematic Bacteriology. Holt JG (Ed.). Williams & Wilkins, MD, USA (1986).
   Google Scholar
• Kloos WE, Schleifer KH. Staphylococcus auricularis sp. nov.: an inhabitant of the human external ear. Int. J. Syst. Bacteriol.22, 9–14 (1983).
   Google Scholar
• Williams RE. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol. Rev.27, 56–71 (1963).
   PubMedGoogle Scholar
• Armstrong-Esther CA. Carriage patterns of Staphylococcus aureus in a healthy non-hospital population of adults and children. Ann. Hum. Biol.3, 221–227 (1976).
   PubMed Web of Science ®Google Scholar
• Ridley M. Perineal carriage of Staph. aureus. Br. Med. J.1, 270–273 (1959).
   PubMed Web of Science ®Google Scholar
• Wertheim HF, Verveer J, Boelens HA, van Belkum A, Verbrugh HA, Vos MC. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Antimicrob. Agents Chemother.49, 1465–1467 (2005).
   PubMed Web of Science ®Google Scholar
• Eriksen NH, Espersen F, Rosdahl VT, Jensen K. Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol. Infect.115, 51–60 (1995).
   PubMed Web of Science ®Google Scholar
• Kluytmans JA, Wertheim HF. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection33, 3–8 (2005).
   PubMed Web of Science ®Google Scholar
• Wertheim HF, Melles DC, Vos MC et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis.5, 751–762 (2005).
   PubMed Web of Science ®Google Scholar
• Kloos WE, Musselwhite MS. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl. Microbiol.30, 381–385 (1975).
   PubMedGoogle Scholar
• Kloos WE, Schleifer KH. Isolation and characterization of staphylococci from human skin. II: description of four new species: Staphylococcus warneri, Staphylococcus capitis, Staphylococcus hominis and Staphylococcus simulans. Int. J. Syst. Bacteriol.25, 62–79 (1975).
   Google Scholar
• Devriese LA, Schleifer KH, Adegoke GO. Identification of coagulase-negative staphylococci from farm animals. J. Appl. Bacteriol.58, 45–55 (1985).
   PubMedGoogle Scholar
• Nagase N, Sasaki A, Yamashita K et al. Isolation and species distribution of staphylococci from animal and human skin. J. Vet. Med. Sci.64, 245–250 (2002).
   PubMed Web of Science ®Google Scholar
• Talan DA, Staatz D, Staatz A, Goldstein EJ, Singer K, Overturf GD. Staphylococcus intermedius in canine gingiva and canine-inflicted human wound infections: laboratory characterization of a newly recognized zoonotic pathogen. J. Clin. Microbiol.27, 78–81 (1989).
   PubMed Web of Science ®Google Scholar
• Otto M. Virulence factors of the coagulase-negative staphylococci. Front. Biosci.9, 841–863 (2004).
   PubMed Web of Science ®Google Scholar
• Lowy FD. Staphylococcus aureus infections. N. Engl. J. Med.339, 520–532 (1998).
   PubMed Web of Science ®Google Scholar
• Etienne J, Pangon B, Leport C et al.Staphylococcus lugdunensis endocarditis. Lancet1, 390 (1989).
   PubMedGoogle Scholar
• Zinkernagel AS, Zinkernagel MS, Elzi MV et al. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature. Infection36, 314–321 (2008).
   PubMed Web of Science ®Google Scholar
• National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control32, 470–485 (2004).
   PubMed Web of Science ®Google Scholar
• Vuong C, Otto M. Staphylococcus epidermidis infections. Microbes Infect.4, 481–489 (2002).
   PubMed Web of Science ®Google Scholar
• Jordan PA, Iravani A, Richard GA, Baer H. Urinary tract infection caused by Staphylococcus saprophyticus. J. Infect. Dis.142, 510–515 (1980).
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Pfaller MA, Schmitz FJ et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin. Infect. Dis.32(Suppl. 2), S114–S132 (2001).
   PubMed Web of Science ®Google Scholar
• Lowy FD. Antimicrobial resistance: the example of Staphylococcus aureus. J. Clin. Invest.111, 1265–1273 (2003).
   PubMed Web of Science ®Google Scholar
• Oliveira DC, Tomasz A, de Lencastre H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect. Dis.2, 180–189 (2002).
   PubMed Web of Science ®Google Scholar
• Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis.7, 178–182 (2001).
   PubMed Web of Science ®Google Scholar
• Klevens RM, Morrison MA, Nadle J et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA298, 1763–1771 (2007).
   PubMed Web of Science ®Google Scholar
• Raad I, Alrahwan A, Rolston K. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin. Infect. Dis.26, 1182–1187 (1998).
   PubMed Web of Science ®Google Scholar
• Hanssen AM, Kjeldsen G, Sollid JU. Local variants of Staphylococcal cassette chromosome mec in sporadic methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococci: evidence of horizontal gene transfer? Antimicrob. Agents Chemother.48, 285–296 (2004).
   PubMed Web of Science ®Google Scholar
• Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev.13, 16–34 (2000).
   PubMed Web of Science ®Google Scholar
• DeLeo FR, Diep BA, Otto M. Host defense and pathogenesis in Staphylococcus aureus infections. Infect. Dis. Clin. North Am.23, 17–34 (2009).
   PubMed Web of Science ®Google Scholar
• Otto M. Staphylococcus epidermidis – the ‘accidental’ pathogen. Nat. Rev. Microbiol.7, 555–567 (2009).
   PubMed Web of Science ®Google Scholar
• von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N. Engl. J. Med.344, 11–16 (2001).
   PubMed Web of Science ®Google Scholar
• Nouwen JL, Fieren MW, Snijders S, Verbrugh HA, van Belkum A. Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections. Kidney Int.67, 1084–1092 (2005).
   PubMed Web of Science ®Google Scholar
• White A. Increased infection rates in heavy nasal carriers of coagulase-positive staphylococci. Antimicrob. Agents Chemother. (Bethesda)161, 667–670 (1963).
   PubMedGoogle Scholar
• Foster TJ, Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol.6, 484–488 (1998).
   PubMed Web of Science ®Google Scholar
• Patti JM, Allen BL, McGavin MJ, Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol.48, 585–617 (1994).
   PubMed Web of Science ®Google Scholar
• Mazmanian SK, Liu G, Ton-That H, Schneewind O. Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science285, 760–763 (1999).
   PubMed Web of Science ®Google Scholar
• Ton-That H, Mazmanian SK, Faull KF, Schneewind O. Anchoring of surface proteins to the cell wall of Staphylococcus aureus. Sortase catalyzed in vitro transpeptidation reaction using LPXTG peptide and NH(2)-Gly(3) substrates. J. Biol. Chem.275, 9876–9881 (2000).
   PubMed Web of Science ®Google Scholar
• Otto M. Staphylococcal biofilms. Curr. Top. Microbiol. Immunol.322, 207–228 (2008).
   PubMed Web of Science ®Google Scholar
• Glaser L. Bacterial cell surface polysaccharides. Annu. Rev. Biochem.42, 91–112 (1973).
   PubMed Web of Science ®Google Scholar
• Mack D, Fischer W, Krokotsch A et al. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear β-1,6-linked glucosaminoglycan: purification and structural analysis. J. Bacteriol.178, 175–183 (1996).
   PubMed Web of Science ®Google Scholar
• Vuong C, Kocianova S, Voyich JM et al. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J. Biol. Chem.279, 54881–54886 (2004).
   PubMed Web of Science ®Google Scholar
• Hussain M, Herrmann M, von Eiff C, Perdreau-Remington F, Peters G. A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect. Immun.65, 519–524 (1997).
   PubMed Web of Science ®Google Scholar
• Conrady DG, Brescia CC, Horii K, Weiss AA, Hassett DJ, Herr AB. A zinc-dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms. Proc. Natl Acad. Sci. USA105, 19456–19461 (2008).
   PubMed Web of Science ®Google Scholar
• Rohde H, Burdelski C, Bartscht K et al. Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Mol. Microbiol.55, 1883–1895 (2005).
   PubMed Web of Science ®Google Scholar
• Banner MA, Cunniffe JG, Macintosh RL et al. Localized tufts of fibrils on Staphylococcus epidermidis NCTC 11047 are comprised of the accumulation-associated protein. J. Bacteriol.189, 2793–2804 (2007).
   PubMed Web of Science ®Google Scholar
• Merino N, Toledo-Arana A, Vergara-Irigaray M et al. Protein A-mediated multicellular behavior in Staphylococcus aureus. J. Bacteriol.191, 832–843 (2009).
   PubMed Web of Science ®Google Scholar
• Vergara-Irigaray M, Valle J, Merino N et al. Relevant role of FnBPs in Staphylococcus aureus biofilm associated foreign-body infections. Infect. Immun.77, 3978–3991 (2009).
   PubMed Web of Science ®Google Scholar
• O’Neill E, Pozzi C, Houston P et al. A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J. Bacteriol.190, 3835–3850 (2008).
   PubMed Web of Science ®Google Scholar
• Rogers KL, Rupp ME, Fey PD. The presence of icaADBC is detrimental to the colonization of human skin by Staphylococcus epidermidis. Appl. Environ. Microbiol.74, 6155–6157 (2008).
   PubMed Web of Science ®Google Scholar
• Gill SR, Fouts DE, Archer GL et al. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol.187, 2426–2438 (2005).
   PubMed Web of Science ®Google Scholar
• Graham JE, Wilkinson BJ. Staphylococcus aureus osmoregulation: roles for choline, glycine betaine, proline, and taurine. J. Bacteriol.174, 2711–2716 (1992).
   PubMed Web of Science ®Google Scholar
• Brook I. Bacterial interference. Crit. Rev. Microbiol.25, 155–172 (1999).
   PubMed Web of Science ®Google Scholar
• Jack RW, Tagg JR, Ray B. Bacteriocins of gram-positive bacteria. Microbiol. Rev.59, 171–200 (1995).
   PubMedGoogle Scholar
• Bierbaum G, Sahl HG. Lantibiotics: mode of action, biosynthesis and bioengineering. Curr. Pharm. Biotechnol.10, 2–18 (2009).
   PubMed Web of Science ®Google Scholar
• Bierbaum G, Gotz F, Peschel A, Kupke T, van de Kamp M, Sahl HG. The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7. Antonie Van Leeuwenhoek69, 119–127 (1996).
   PubMed Web of Science ®Google Scholar
• Ekkelenkamp MB, Hanssen M, Danny Hsu ST et al. Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis. FEBS Lett.579, 1917–1922 (2005).
   PubMed Web of Science ®Google Scholar
• Kaletta C, Entian KD, Kellner R, Jung G, Reis M, Sahl HG. Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch. Microbiol.152, 16–19 (1989).
   PubMed Web of Science ®Google Scholar
• Schnell N, Entian KD, Schneider U et al. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature333, 276–278 (1988).
   PubMed Web of Science ®Google Scholar
• van de Kamp M, van den Hooven HW, Konings RN et al. Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7. Eur. J. Biochem.230, 587–600 (1995).
   PubMedGoogle Scholar
• Aso Y, Nagao J, Koga H et al. Heterologous expression and functional analysis of the gene cluster for the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1. J. Biosci. Bioeng.98, 429–436 (2004).
   PubMedGoogle Scholar
• Aso Y, Sashihara T, Nagao J et al. Characterization of a gene cluster of Staphylococcus warneri ISK-1 encoding the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1. Biosci. Biotechnol. Biochem.68, 1663–1671 (2004).
   PubMed Web of Science ®Google Scholar
• Schnell N, Entian KD, Gotz F, Horner T, Kellner R, Jung G. Structural gene isolation and prepeptide sequence of gallidermin, a new lanthionine containing antibiotic. FEMS Microbiol. Lett.49, 263–267 (1989).
   PubMedGoogle Scholar
• Navaratna MA, Sahl HG, Tagg JR. Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene. Infect. Immun.67, 4268–4271 (1999).
   PubMed Web of Science ®Google Scholar
• Draper LA, Ross RP, Hill C, Cotter PD. Lantibiotic immunity. Curr. Protein Pept. Sci.9, 39–49 (2008).
   PubMed Web of Science ®Google Scholar
• Otto M, Peschel A, Gotz F. Producer self-protection against the lantibiotic epidermin by the ABC transporter EpiFEG of Staphylococcus epidermidis Tu3298. FEMS Microbiol. Lett.166, 203–211 (1998).
   PubMed Web of Science ®Google Scholar
• Peschel A, Gotz F. Analysis of the Staphylococcus epidermidis genes epiF, -E, and -G involved in epidermin immunity. J. Bacteriol.178, 531–536 (1996).
   PubMed Web of Science ®Google Scholar
• Saris PE, Immonen T, Reis M, Sahl HG. Immunity to lantibiotics. Antonie Van Leeuwenhoek69, 151–159 (1996).
   PubMed Web of Science ®Google Scholar
• Diep BA, Gill SR, Chang RF et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet367, 731–739 (2006).
   PubMed Web of Science ®Google Scholar
• Otto M, Gotz F. ABC transporters of staphylococci. Res. Microbiol.152, 351–356 (2001).
   PubMed Web of Science ®Google Scholar
• Donvito B, Etienne J, Denoroy L, Greenland T, Benito Y, Vandenesch F. Synergistic hemolytic activity of Staphylococcus lugdunensis is mediated by three peptides encoded by a non-agr genetic locus. Infect. Immun.65, 95–100 (1997).
   PubMed Web of Science ®Google Scholar
• Mehlin C, Headley CM, Klebanoff SJ. An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization. J. Exp. Med.189, 907–918 (1999).
   PubMed Web of Science ®Google Scholar
• Wang R, Braughton KR, Kretschmer D et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med.13, 1510–1514 (2007).
   PubMed Web of Science ®Google Scholar
• Beaudet R, Bisaillon JG, Saheb SA, Sylvestre M. Production, purification, and preliminary characterization of a gonococcal growth inhibitor produced by a coagulase-negative staphylococcus isolated from the urogenital flora. Antimicrob. Agents Chemother.22, 277–283 (1982).
   PubMed Web of Science ®Google Scholar
• Dhople VM, Nagaraj R. Generation of analogs having potent antimicrobial and hemolytic activities with minimal changes from an inactive 16-residue peptide corresponding to the helical region of Staphylococcus aureus δ-toxin. Protein Eng.8, 315–318 (1995).
   PubMedGoogle Scholar
• Dhople VM, Nagaraj R. Conformation and activity of δ-lysin and its analogs. Peptides26, 217–225 (2005).
   PubMed Web of Science ®Google Scholar
• Watson DC, Yaguchi M, Bisaillon JG, Beaudet R, Morosoli R. The amino acid sequence of a gonococcal growth inhibitor from Staphylococcus haemolyticus. Biochem. J.252, 87–93 (1988).
   PubMed Web of Science ®Google Scholar
• Dhople VM, Nagaraj R. δ-toxin, unlike melittin, has only hemolytic activity and no antimicrobial activity: rationalization of this specific biological activity. Biosci. Rep.13, 245–250 (1993).
   PubMed Web of Science ®Google Scholar
• Miller MB, Bassler BL. Quorum sensing in bacteria. Annu. Rev. Microbiol.55, 165–199 (2001).
   PubMed Web of Science ®Google Scholar
• Camilli A, Bassler BL. Bacterial small-molecule signaling pathways. Science311, 1113–1116 (2006).
   PubMed Web of Science ®Google Scholar
• Ji G, Beavis RC, Novick RP. Cell density control of staphylococcal virulence mediated by an octapeptide pheromone. Proc. Natl Acad. Sci. USA92, 12055–12059 (1995).
   PubMed Web of Science ®Google Scholar
• Mayville P, Ji G, Beavis R et al. Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence. Proc. Natl Acad. Sci. USA96, 1218–1223 (1999).
   PubMed Web of Science ®Google Scholar
• Otto M, Sussmuth R, Jung G, Gotz F. Structure of the pheromone peptide of the Staphylococcus epidermidisagr system. FEBS Lett.424, 89–94 (1998).
   PubMed Web of Science ®Google Scholar
• Ji G, Beavis R, Novick RP. Bacterial interference caused by autoinducing peptide variants. Science276, 2027–2030 (1997).
   PubMed Web of Science ®Google Scholar
• Otto M, Sussmuth R, Vuong C, Jung G, Gotz F. Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidisagr pheromone and derivatives. FEBS Lett.450, 257–262 (1999).
   PubMed Web of Science ®Google Scholar
• Lina G, Boutite F, Tristan A, Bes M, Etienne J, Vandenesch F. Bacterial competition for human nasal cavity colonization: role of Staphylococcal agr alleles. Appl. Environ. Microbiol.69, 18–23 (2003).
   PubMed Web of Science ®Google Scholar
• Etz H, Minh DB, Henics T et al. Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc. Natl Acad. Sci. USA99, 6573–6578 (2002).
   PubMed Web of Science ®Google Scholar
• Harrison LM, Morris JA, Lauder RM, Telford DR. The effect of Staphylococcus aureus carriage in late pregnancy on antibody levels to staphylococcal toxins in cord blood and breast milk. FEMS Immunol. Med. Microbiol.54, 137–143 (2008).
   PubMedGoogle Scholar
• Verkaik NJ, de Vogel CP, Boelens HA et al. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J. Infect. Dis.199, 625–632 (2009).
   PubMed Web of Science ®Google Scholar
• Wertheim HF, Vos MC, Ott A et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet364, 703–705 (2004).
   PubMed Web of Science ®Google Scholar
• Langley R, Wines B, Willoughby N, Basu I, Proft T, Fraser JD. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc α RI binding and serum killing of bacteria. J. Immunol.174, 2926–2933 (2005).
   PubMed Web of Science ®Google Scholar
• Forsgren A, Nordstrom K. Protein A from Staphylococcus aureus: the biological significance of its reaction with IgG. Ann. NY Acad. Sci.236, 252–266 (1974).
   PubMed Web of Science ®Google Scholar
• Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect.5, 1317–1327 (2003).
   PubMed Web of Science ®Google Scholar
• Foster TJ. Immune evasion by staphylococci. Nat. Rev. Microbiol.3, 948–958 (2005).
   PubMed Web of Science ®Google Scholar
• Rooijakkers SH, van Kessel KP, van Strijp JA. Staphylococcal innate immune evasion. Trends Microbiol.13, 596–601 (2005).
   PubMed Web of Science ®Google Scholar
• Boman HG. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol.13, 61–92 (1995).
   PubMed Web of Science ®Google Scholar
• Hancock RE, Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol.8, 402–410 (2000).
   PubMed Web of Science ®Google Scholar
• Zasloff M. Antimicrobial peptides of multicellular organisms. Nature415, 389–395 (2002).
   PubMed Web of Science ®Google Scholar
• Giuliani A, Pirri G, Bozzi A, Di Giulio A, Aschi M, Rinaldi AC. Antimicrobial peptides: natural templates for synthetic membrane-active compounds. Cell. Mol. Life Sci.65, 2450–2460 (2008).
   PubMed Web of Science ®Google Scholar
• Mookherjee N, Hancock RE. Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell. Mol. Life Sci.64, 922–933 (2007).
   PubMed Web of Science ®Google Scholar
• Di Nardo A, Vitiello A, Gallo RL. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol.170, 2274–2278 (2003).
   PubMed Web of Science ®Google Scholar
• Agerberth B, Charo J, Werr J et al. The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations. Blood96, 3086–3093 (2000).
   PubMed Web of Science ®Google Scholar
• Lee DY, Yamasaki K, Rudsil J et al. Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill propionibacterium acnes. J. Invest. Dermatol.128, 1863–1866 (2008).
   PubMed Web of Science ®Google Scholar
• Nagy I, Pivarcsi A, Kis K et al.Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect.8, 2195–2205 (2006).
   PubMed Web of Science ®Google Scholar
• Davidson DJ, Currie AJ, Reid GS et al. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T-cell polarization. J. Immunol.172, 1146–1156 (2004).
   PubMed Web of Science ®Google Scholar
• De Y, Chen Q, Schmidt AP et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med.192, 1069–1074 (2000).
   PubMed Web of Science ®Google Scholar
• Yang D, Chertov O, Bykovskaia SN et al. β-defensins: linking innate and adaptive immunity through dendritic and T-cell CCR6. Science286, 525–528 (1999).
   PubMed Web of Science ®Google Scholar
• Schittek B, Hipfel R, Sauer B et al. Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat. Immunol.2, 1133–1137 (2001).
   PubMed Web of Science ®Google Scholar
• Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol.3, 710–720 (2003).
   PubMed Web of Science ®Google Scholar
• Harder J, Schroder JM. Antimicrobial peptides in human skin. Chem. Immunol. Allergy86, 22–41 (2005).
   PubMedGoogle Scholar
• Harder J, Meyer-Hoffert U, Wehkamp K, Schwichtenberg L, Schroder JM. Differential gene induction of human β-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid. J. Invest. Dermatol.123, 522–529 (2004).
   PubMed Web of Science ®Google Scholar
• Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem.276, 5707–5713 (2001).
   PubMed Web of Science ®Google Scholar
• Yang D, Chertov O, Oppenheim JJ. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J. Leukoc. Biol.69, 691–697 (2001).
   PubMed Web of Science ®Google Scholar
• Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol.75, 39–48 (2004).
   PubMed Web of Science ®Google Scholar
• Durr UH, Sudheendra US, Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophy.s Acta1758, 1408–1425 (2006).
   PubMed Web of Science ®Google Scholar
• Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, Gudmundsson GH. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl Acad. Sci. USA92, 195–199 (1995).
   PubMed Web of Science ®Google Scholar
• Cowland JB, Johnsen AH, Borregaard N. hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett.368, 173–176 (1995).
   PubMed Web of Science ®Google Scholar
• Murakami M, Ohtake T, Dorschner RA, Schittek B, Garbe C, Gallo RL. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J. Invest. Dermatol.119, 1090–1095 (2002).
   PubMed Web of Science ®Google Scholar
• Wang TT, Nestel FP, Bourdeau V et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol.173, 2909–2912 (2004).
   PubMed Web of Science ®Google Scholar
• Rieg S, Garbe C, Sauer B, Kalbacher H, Schittek B. Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions. Br. J. Dermatol.151, 534–539 (2004).
   PubMed Web of Science ®Google Scholar
• Steffen H, Rieg S, Wiedemann I et al. Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob. Agents Chemother.50, 2608–2620 (2006).
   PubMed Web of Science ®Google Scholar
• Richards AM, Nicholls MG, Lewis L, Lainchbury JG. Adrenomedullin. Clin. Sci. (Lond.)91, 3–16 (1996).
   PubMed Web of Science ®Google Scholar
• Allaker RP, Kapas S. Adrenomedullin and mucosal defence: interaction between host and microorganism. Regul. Pept.112, 147–152 (2003).
   PubMed Web of Science ®Google Scholar
• Allaker RP, Zihni C, Kapas S. An investigation into the antimicrobial effects of adrenomedullin on members of the skin, oral, respiratory tract and gut microflora. FEMS Immunol. Med. Microbiol.23, 289–293 (1999).
   PubMed Web of Science ®Google Scholar
• Chipman DM, Sharon N. Mechanism of lysozyme action. Science165, 454–465 (1969).
   PubMed Web of Science ®Google Scholar
• Neu HC, Dreyfus J 3rd, Canfield RE. Effect of human lysozyme on gram-positive and gram-negative bacteria. Antimicrob. Agents Chemother. (Bethesda)8, 442–444 (1968).
   PubMedGoogle Scholar
• Bera A, Biswas R, Herbert S, Gotz F. The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity. Infect. Immun.74, 4598–4604 (2006).
   PubMed Web of Science ®Google Scholar
• Bera A, Herbert S, Jakob A, Vollmer W, Gotz F. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol. Microbiol.55, 778–787 (2005).
   PubMed Web of Science ®Google Scholar
• Simpson AJ, Maxwell AI, Govan JR, Haslett C, Sallenave JM. Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett.452, 309–313 (1999).
   PubMed Web of Science ®Google Scholar
• Williams SE, Brown TI, Roghanian A, Sallenave JM. SLPI and elafin: one glove, many fingers. Clin. Sci. (Lond.)110, 21–35 (2006).
   PubMed Web of Science ®Google Scholar
• Glaser R, Harder J, Lange H, Bartels J, Christophers E, Schroder JM. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat. Immunol.6, 57–64 (2005).
   PubMed Web of Science ®Google Scholar
• Corbin BD, Seeley EH, Raab A et al. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science319, 962–965 (2008).
   PubMed Web of Science ®Google Scholar
• Zhang J, Dyer KD, Rosenberg HF. Human RNase 7, a new cationic ribonuclease of the RNase A superfamily. Nucleic Acids Res.31, 602–607 (2003).
   PubMed Web of Science ®Google Scholar
• Dorschner RA, Lopez-Garcia B, Peschel A et al. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J.20, 35–42 (2006).
   PubMed Web of Science ®Google Scholar
• Schittek B, Paulmann M, Senyurek I, Steffen H. The role of antimicrobial peptides in human skin and in skin infectious diseases. Infect. Disord. Drug Targets8, 135–143 (2008).
   PubMedGoogle Scholar
• Aly R, Maibach HI, Shinefield HR. Microbial flora of atopic dermatitis. Arch. Dermatol.113, 780–782 (1977).
   PubMedGoogle Scholar
• Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br. J. Dermatol.90, 525–530 (1974).
   PubMed Web of Science ®Google Scholar
• Nomura I, Goleva E, Howell MD et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J. Immunol.171, 3262–3269 (2003).
   PubMed Web of Science ®Google Scholar
• Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med.347, 1151–1160 (2002).
   PubMed Web of Science ®Google Scholar
• Rieg S, Steffen H, Seeber S et al. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J. Immunol.174, 8003–8010 (2005).
   PubMed Web of Science ®Google Scholar
• Harder J, Schroder JM. Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J. Leukoc. Biol.77, 476–486 (2005).
   PubMed Web of Science ®Google Scholar
• Chronnell CM, Ghali LR, Ali RS et al. Human β defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J. Invest. Dermatol.117, 1120–1125 (2001).
   PubMed Web of Science ®Google Scholar
• Philpott MP. Defensins and acne. Mol. Immunol.40, 457–462 (2003).
   PubMed Web of Science ®Google Scholar
• Gallo RL, Kim KJ, Bernfield M et al. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J. Biol. Chem.272, 13088–13093 (1997).
   PubMed Web of Science ®Google Scholar
• Pestonjamasp VK, Huttner KH, Gallo RL. Processing site and gene structure for the murine antimicrobial peptide CRAMP. Peptides22, 1643–1650 (2001).
   PubMed Web of Science ®Google Scholar
• Nizet V, Ohtake T, Lauth X et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature414, 454–457 (2001).
   PubMed Web of Science ®Google Scholar
• Quinn GA, Cole AM. Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium. Immunology122, 80–89 (2007).
   PubMed Web of Science ®Google Scholar
• Peschel A, Sahl HG. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol.4, 529–536 (2006).
   PubMed Web of Science ®Google Scholar
• Peschel A. How do bacteria resist human antimicrobial peptides? Trends Microbiol.10, 179–186 (2002).
   PubMed Web of Science ®Google Scholar
• Lai Y, Villaruz AE, Li M, Cha DJ, Sturdevant DE, Otto M. The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol. Microbiol.63, 497–506 (2007).
   PubMed Web of Science ®Google Scholar
• Sieprawska-Lupa M, Mydel P, Krawczyk K et al. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother.48, 4673–4679 (2004).
   PubMed Web of Science ®Google Scholar
• Jin T, Bokarewa M, Foster T, Mitchell J, Higgins J, Tarkowski A. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J. Immunol.172, 1169–1176 (2004).
   PubMed Web of Science ®Google Scholar
• Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol. Microbiol.66, 1136–1147 (2007).
   PubMed Web of Science ®Google Scholar
• Peschel A, Jack RW, Otto M et al.Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J. Exp. Med.193, 1067–1076 (2001).
   PubMed Web of Science ®Google Scholar
• Perego M, Glaser P, Minutello A, Strauch MA, Leopold K, Fischer W. Incorporation of D-alanine into lipoteichoic acid and wall teichoic acid in Bacillus subtilis. Identification of genes and regulation. J. Biol. Chem.270, 15598–15606 (1995).
   PubMed Web of Science ®Google Scholar
• Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Gotz F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem.274, 8405–8410 (1999).
   PubMed Web of Science ®Google Scholar
• Vuong C, Voyich JM, Fischer ER et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell. Microbiol.6, 269–275 (2004).
   PubMed Web of Science ®Google Scholar
• Hachmann AB, Angert ER, Helmann JD. Genetic analysis of factors affecting susceptibility of Bacillus subtilis to daptomycin. Antimicrob. Agents Chemother.53, 1598–1609 (2009).
   PubMed Web of Science ®Google Scholar
• Otto M. Bacterial sensing of antimicrobial peptides. Contrib. Microbiol.16, 136–149 (2009).
   PubMedGoogle Scholar
• Bader MW, Sanowar S, Daley ME et al. Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell122, 461–472 (2005).
   PubMed Web of Science ®Google Scholar
• Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M. Gram-positive three-component antimicrobial peptide-sensing system. Proc. Natl Acad. Sci. USA104, 9469–9474 (2007).
   PubMed Web of Science ®Google Scholar
• Coates T, Bax R, Coates A. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. J. Antimicrob. Chemother.64, 9–15 (2009).
   PubMed Web of Science ®Google Scholar
• Kluytmans J, Harbarth S. Methicillin-resistant Staphylococcus aureus decolonization: ‘yes, we can,’ but will it help? Infect. Control Hosp. Epidemiol.30, 633–635 (2009).
   PubMed Web of Science ®Google Scholar
• Kiser KB, Cantey-Kiser JM, Lee JC. Development and characterization of a Staphylococcus aureus nasal colonization model in mice. Infect. Immun.67, 5001–5006 (1999).
   PubMed Web of Science ®Google Scholar
• Kokai-Kun JF. The cotton rat as a model for Staphylococcus aureus nasal colonization in humans: cotton rat S. aureus nasal colonization model. Methods Mol. Biol.431, 241–254 (2008).
   PubMedGoogle Scholar